Lesion-level Quantitative Post-therapy SPECT/CT During 177 Lu-DOTATATE PRRT for NET Liver Metastases
Anticancer Research · 2026
DOI: 10.21873/anticanres.18374 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Anticancer Research, 2026. Verfasst von Kenta Konishi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Hamamatsu University School of Medicine, Hamamatsu, Japan kkonishi@hama-med.ac.jp. Hauptthemen laut MEDLINE: Liver Neoplasms, Single Photon Emission Computed Tomography Computed Tomography, Radiopharmaceuticals, Neuroendocrine Tumors.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Hamamatsu University School of Medicine, Hamamatsu, Japan kkonishi@hama-med.ac.jp.
- Department of Radiation Oncology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Zitieren
APA
Konishi, K., Wakabayashi, K., Ikenohira, T., Yamashita, R., Aramaki, S., Ito, S., & Nakamura, K. (2026). Lesion-level Quantitative Post-therapy SPECT/CT During 177 Lu-DOTATATE PRRT for NET Liver Metastases. Anticancer Research. https://doi.org/10.21873/anticanres.18374
Vancouver
Konishi K, Wakabayashi K, Ikenohira T, Yamashita R, Aramaki S, Ito S, et al. Lesion-level Quantitative Post-therapy SPECT/CT During 177 Lu-DOTATATE PRRT for NET Liver Metastases. Anticancer Research. 2026. doi:10.21873/anticanres.18374
BibTeX
@article{Konishi2026,
author = {Konishi, Kenta and Wakabayashi, Kohei and Ikenohira, Tsutomu and Yamashita, Rintaro and Aramaki, Shuhei and Ito, Shun and Nakamura, Katsumasa},
title = {Lesion-level Quantitative Post-therapy SPECT/CT During 177 Lu-DOTATATE PRRT for NET Liver Metastases},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18374}
}
EUVIMED